KAUTI
Search
- Page Path
- HOME > Search
Original Article
- Rates and Risk Factors of Bacteriuria in Patients with Bladder Cancer Who Underwent Treatment with Bacillus Calmette-Guérin
- Seong Jong Eun, Myung Soo Kim, Seung Il Jung, Hyun-Jung Choi, Ho Seok Chung, Eu Chang Hwang, Dong Deuk Kwon
- Urogenit Tract Infect 2020;15(2):47-53. Published online August 31, 2020
- DOI: https://doi.org/10.14777/uti.2020.15.2.47
-
Abstract
PDF
PubReader
ePub - Purpose: This study evaluated the rate and predictors of bacteriuria in patients who underwent transurethral resection of bladder tumor (TURBT) and Bacillus Calmette-Guérin (BCG) treatment.
Materials and Methods: We prospectively evaluated 266 patients who underwent TURBT and intravesical BCG treatment between January 2017 and September 2019. Urinalysis and urine culture were performed at the baseline, one to two weeks after TURBT and weekly during the BCG treatment period. The primary outcomes were the bacteriuria rates in BCG-treated patients, while the secondary outcomes were the risk factors of bacteriuria during BCG treatments.
Results: Of the 266 patients, the rate of bacteriuria was 4.5% before TURBT, 5.3% in the postoperative period, and 24.4% in the BCG treatment period. After BCG instillation, urinalysis showed that 204 and 38 patients tested positive for pyuria and nitrite, respectively. Multivariate analysis indicated that the risk factors associated with bacteriuria during BCG treatment included age (odds ratio [OR]: 1.06; p=0.003), sex (female) (OR, 5.41; p=0.007), diabetes mellitus (DM) (OR, 2.82; p=0.023), postoperative bacteriuria (OR, 8.08; p=0.032), bacterial counts>100/µl in urine flow cytometry (OR, 29.72; p<0.001), and positive urine nitrite test (OR, 6.20; p=0.001) at the time of positive urine culture sampling.
Conclusions: Approximately 25% of the patients suffered from bacteriuria during intravesical BCG treatment. Old age, female sex, DM, and postoperative bacteriuria were found to be the risk factors of bacteriuria during BCG treatment. Predictive factors could aid in clinical decisions during BCG treatments as well as decisions on BCG discontinuation. -
Citations
Citations to this article as recorded by
- MESANE KANSERİ ve ÜRİNER STOMASI OLAN HASTANIN EVDE BAKIMI
Neşe İşcan Ayyıldız
Paramedik ve Acil Sağlık Hizmetleri Dergisi.2024; 5(1): 31. CrossRef - Mesane Kanserinde İntravezikal Bacille Calmette- Guerin (BCG) Uygulaması ve Hemşirenin Sorumlulukları
Ayla YAVUZ KARAMANOĞLU, Ali Ersin ZÜMRÜTBAŞ
Adnan Menderes Üniversitesi Sağlık Bilimleri Fakültesi Dergisi.2023; 7(1): 256. CrossRef
- MESANE KANSERİ ve ÜRİNER STOMASI OLAN HASTANIN EVDE BAKIMI
- 57 View
- 1 Download
- 2 Crossref
First
Prev
